Evaluation of an intensive, private, community, upper limb rehabilitation program for people with chronic stroke: a mixed methods case series.
Alana Spirou, Ines Serrada, Kate Smedley and 2 others
One of two people with chronic stroke who completed 18 hours of intensive upper limb therapy over six weeks showed an arm impairment gain above the minimal clinically important difference.
The other did not. Self-efficacy went up for one and down for the other.
Key findings
1Both participants showed small improvements in upper limb impairment (3 and 6 points on the FMA-UE), with only one exceeding the minimal clinically important difference. Arm activity changes were minimal (0 and 3 points on the ARAT).
2Self-efficacy increased by 11 points for one participant and decreased by 15 points for the other. Quality of life showed small and inconsistent changes between the two.
3Home exercise completion was low: 41.6% for one participant and 0% for the other, despite both understanding its importance.
Still to come
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Two participants is not enough to draw any conclusion about whether the program works. There was no comparison group, so you cannot separate the program's effect from natural variation or the attention of having a therapist three times a week. No follow-up beyond four weeks, so it is unknown whether any gains lasted. Home exercise was barely done (41.6% and 0% completion), so the total practice dose was far below the intended 12-24 hours of home work. The program was delivered as a real clinical service without detailed session-by-session logs, so the exact content of each session is not documented. Recruitment was slow and occurred over the Christmas holiday period, which may have affected who was available to participate.
Declared interests
The authors declared no external financial support. However, the program being evaluated (Neuroboost) is offered by One Rehabilitation Service, and the authors appear to be associated with that clinic. The outcome assessor was explicitly not associated with the clinic or intervention delivery, but the program design and delivery were the authors' own service.
The easy way to misread this
Do not read the 6-point FMA-UE improvement in one participant as evidence that this program works. It is one person out of two, with no control group, and the other participant's self-efficacy actually decreased by 15 points. The authors themselves call this a preliminary signal and recommend a larger controlled trial before any conclusions can be drawn.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →